Cefixime penetration in human renal parenchyma.
The diffusion of cefixime, a new orally active expanded-spectrum cephalosporin, was studied in 12 patients undergoing nephrectomy after receiving 200-mg oral doses every 12 h for 2 days. The patients were divided into two groups according to the time of perioperative sampling after the last dose: 4...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1995
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162719/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574508/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1240 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|